RNA-based immunizing agents have enriched the repertoire of technologies used for vaccine development. An analysis of the active clinical trials in early Phase I and Phase I during the year of 2023 ...
IN order to render staphylococcal toxic supernatants safe for use as active immunizing agents, it is customary to incubate them with formalin, in concentrations of 0.3–0.8 per cent at temperatures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results